As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

A new study found bariatric ... and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The new weight-loss drugs have created ... an early-generation GLP-1 drug—cut BMI by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported ...

Then, in 2022 – in a blaze of stardust – the GLP-1 agonist drugs arrived on the ... waxed lyrical about their easy, new-found ...

Ahead, discover all the details you should know when considering type 2 diabetes injections for weight loss. Weight loss injections are prescription ... cover new weight loss medications ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

U.S. consumers pay higher prices for weight loss drugs ... Protection at New York's JFK Airport. CBP agents are on the front lines, intercepting counterfeit prescription drugs, which pour into ...

FreshSplash/Getty Images A new study ... about 5,600 had a prescription for a GLP-1 medication. The study authors stated that people with alcohol use disorder who take a weight-loss drug had ...